ロード中...
Clinical Considerations When Introducing Sodium-Glucose Co-Transporter 2 Inhibition in Patients With Heart Failure
Background: In patients with heart failure (HF), discontinued medical therapy because of adverse events (AE) is associated with high mortality. Patients with type 2 diabetes mellitus (T2DM) treated with sodium-glucose co-transporter 2 inhibitors (SGLT2i) have a lower risk of HF, but AE sometimes occ...
保存先:
| 出版年: | Circ Rep |
|---|---|
| 主要な著者: | , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
The Japanese Circulation Society
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7929704/ https://ncbi.nlm.nih.gov/pubmed/33693174 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1253/circrep.CR-19-0080 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|